Lifecore Biomedical Inc
Research Lifecore Biomedical Inc (LFCR) on Bullrun: market cap USD 174.91M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLFCR
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 174.91M
- Financial periodQ2 2026
- RevenueUSD 34.17M
- Net income-USD 6.16M
- Free cash flow-USD 2.70M
- Gross margin35.3%
Valuation Snapshot
latest market cap is USD 174.91M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 128.87M | -USD 38.70M | -USD 13.62M | 31.3% | -1.27 | USD 8.27M | USD 133.87M | USD 1.34M |
| FY2024 | USD 128.26M | USD 12.00M | -USD 18.14M | 32.6% | 0.33 | USD 8.46M | USD 101.76M | USD 11.32M |
| FY2023 | USD 103.27M | -USD 99.60M | n/a | 27.1% | -3.32 | USD 19.09M | USD 84.84M | -USD 4.23M |
| FY2022 | USD 111.27M | -USD 116.70M | -USD 48.82M | 35.1% | -3.97 | USD 991.00K | USD 98.18M | USD 87.82M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 174.91M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 306.57M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 275.10M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 188.54M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 196.32M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 327.24M | n/a | n/a | n/a |
About Lifecore Biomedical Inc
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Lifecore Biomedical Inc's market cap?
Lifecore Biomedical Inc's market capitalization is USD 174.91M.
What does Lifecore Biomedical Inc do?
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities.